NO991619D0 - Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper - Google Patents

Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper

Info

Publication number
NO991619D0
NO991619D0 NO991619A NO991619A NO991619D0 NO 991619 D0 NO991619 D0 NO 991619D0 NO 991619 A NO991619 A NO 991619A NO 991619 A NO991619 A NO 991619A NO 991619 D0 NO991619 D0 NO 991619D0
Authority
NO
Norway
Prior art keywords
treatment
nasal polyps
atpase inhibitor
atpase
inhibitor
Prior art date
Application number
NO991619A
Other languages
English (en)
Other versions
NO991619L (no
NO321007B1 (no
Inventor
Per Lindberg
Joan Pinas-Masso
Jordi Serra-Carreras
Jan Trofast
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO991619L publication Critical patent/NO991619L/no
Publication of NO991619D0 publication Critical patent/NO991619D0/no
Publication of NO321007B1 publication Critical patent/NO321007B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Otolaryngology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO19991619A 1996-10-11 1999-04-06 Anvendelse av en H+,KC-ATPase-inhibitor og et glukokortikoid ved behandlingen av Widals syndrom og nesepolypper, samt en farmasoytisk formulering som innbefatter en H+,K+-ATPase-inhibitor og et glukokortikoid NO321007B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9603725A SE9603725D0 (sv) 1996-10-11 1996-10-11 New teatment
PCT/SE1997/001651 WO1998016228A1 (en) 1996-10-11 1997-10-01 USE OF AN H+, K+-ATPase INHIBITOR IN THE TREATMENT OF NASAL POLYPS

Publications (3)

Publication Number Publication Date
NO991619L NO991619L (no) 1999-04-06
NO991619D0 true NO991619D0 (no) 1999-04-06
NO321007B1 NO321007B1 (no) 2006-02-27

Family

ID=20404214

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19991619A NO321007B1 (no) 1996-10-11 1999-04-06 Anvendelse av en H+,KC-ATPase-inhibitor og et glukokortikoid ved behandlingen av Widals syndrom og nesepolypper, samt en farmasoytisk formulering som innbefatter en H+,K+-ATPase-inhibitor og et glukokortikoid

Country Status (34)

Country Link
EP (1) EP0946175B1 (no)
JP (1) JP4100713B2 (no)
KR (1) KR100510812B1 (no)
CN (1) CN1146416C (no)
AR (1) AR008886A1 (no)
AT (1) ATE230597T1 (no)
AU (1) AU738310B2 (no)
BR (1) BR9711896A (no)
CA (1) CA2268305C (no)
CZ (1) CZ298799B6 (no)
DE (1) DE69718347T2 (no)
DK (1) DK0946175T3 (no)
EE (1) EE04043B1 (no)
ES (1) ES2188995T3 (no)
HK (1) HK1022848A1 (no)
HU (1) HUP0000036A3 (no)
ID (1) ID23692A (no)
IL (1) IL129324A0 (no)
IS (1) IS1930B (no)
MY (1) MY117918A (no)
NO (1) NO321007B1 (no)
NZ (1) NZ334786A (no)
PL (1) PL190902B1 (no)
PT (1) PT946175E (no)
RS (1) RS49599B (no)
RU (1) RU2197966C2 (no)
SA (1) SA97180641B1 (no)
SE (1) SE9603725D0 (no)
SK (1) SK284252B6 (no)
TR (1) TR199900770T2 (no)
TW (1) TW568784B (no)
UA (1) UA59374C2 (no)
WO (1) WO1998016228A1 (no)
ZA (1) ZA978842B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6846799B1 (en) * 1998-08-18 2005-01-25 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
SI1119349T1 (sl) 1998-08-18 2008-12-31 Univ California Antagonisti receptorja epidermalnega rastnega faktorja za zdravljenje hipersekrecije sluzi v pljučah
US7354894B2 (en) 1998-08-18 2008-04-08 The Regents Of The University Of California Preventing airway mucus production by administration of EGF-R antagonists
WO2003043614A2 (en) * 2001-11-19 2003-05-30 Altana Pharma Ag Reversible proton pump inhibitors for the treatment of airway disorders
WO2003075926A1 (en) * 2002-03-14 2003-09-18 Altana Pharma Ag Use of proton pump inhibitors for the treatment of airway disorders
MXPA04011019A (es) * 2002-05-07 2005-01-25 Altana Pharma Ag Combinacion de un inhibidor de la bomba de protones y un agente respiratorio, para el tratamiento de trastornos de las vias respiratorias.
BR0309808A (pt) * 2002-05-07 2005-03-01 Altana Pharma Ag Combinação para o tratamento de distúrbios das vias aéreas
FR2845915B1 (fr) * 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
DE60323138D1 (de) 2002-12-12 2008-10-02 Nycomed Gmbh Kombinationsarzneimittel aus r,r-formoterol und ciclesonide
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN104408249B (zh) * 2014-11-24 2017-09-26 广州供电局有限公司 单芯电缆导体热性参数的确定方法及***
KR101974504B1 (ko) * 2017-04-10 2019-05-03 재단법인 아산사회복지재단 호산구성 비용종 동물모델

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
GB1571629A (en) * 1977-11-30 1980-07-16 Fisons Ltd Pharmaceutical compositions containing beclomethasone dipropionate

Also Published As

Publication number Publication date
NO991619L (no) 1999-04-06
PT946175E (pt) 2003-04-30
IS1930B (is) 2004-05-18
DE69718347D1 (de) 2003-02-13
PL332692A1 (en) 1999-09-27
EE9900118A (et) 1999-10-15
DE69718347T2 (de) 2003-08-28
DK0946175T3 (da) 2003-03-17
CZ298799B6 (cs) 2008-02-06
IL129324A0 (en) 2000-02-17
TW568784B (en) 2004-01-01
CN1232397A (zh) 1999-10-20
WO1998016228A1 (en) 1998-04-23
SK284252B6 (sk) 2004-12-01
EE04043B1 (et) 2003-06-16
SE9603725D0 (sv) 1996-10-11
HUP0000036A3 (en) 2003-02-28
CZ122999A3 (cs) 1999-09-15
CA2268305C (en) 2006-11-28
PL190902B1 (pl) 2006-02-28
KR100510812B1 (ko) 2005-08-31
TR199900770T2 (xx) 1999-06-21
CA2268305A1 (en) 1998-04-23
ES2188995T3 (es) 2003-07-01
SA97180641B1 (ar) 2005-12-18
HK1022848A1 (en) 2000-08-25
MY117918A (en) 2004-08-30
EP0946175A1 (en) 1999-10-06
AU738310B2 (en) 2001-09-13
IS5021A (is) 1999-04-08
ATE230597T1 (de) 2003-01-15
EP0946175B1 (en) 2003-01-08
NO321007B1 (no) 2006-02-27
BR9711896A (pt) 1999-08-24
YU16399A (sh) 2000-03-21
HUP0000036A2 (hu) 2002-05-29
RS49599B (sr) 2007-06-04
CN1146416C (zh) 2004-04-21
AR008886A1 (es) 2000-02-23
HU0000036D0 (no) 2002-05-29
JP2001508034A (ja) 2001-06-19
ZA978842B (en) 1998-04-14
UA59374C2 (uk) 2003-09-15
SK38499A3 (en) 2000-03-13
KR20000049046A (ko) 2000-07-25
AU4640997A (en) 1998-05-11
RU2197966C2 (ru) 2003-02-10
ID23692A (id) 2000-05-11
NZ334786A (en) 2000-12-22
JP4100713B2 (ja) 2008-06-11

Similar Documents

Publication Publication Date Title
DE69719108D1 (de) Plasmabehandlungsgerät
NO991619D0 (no) Anvendelse av en H+, K+-ATPase-inhibitor i behandlingen av nesepolypper
ATE371457T1 (de) Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen
NO991381L (no) Kombinasjonsterapi for behandling av psykoser
DE69620264D1 (de) Topische teppichbehandlung
NO20014379D0 (no) Anvendelse av Xenon for behandling av Neurointoksikasjoner
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
FI971969A (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
FI20000863A (fi) Uusi hoitomenetelmä
NO991459D0 (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
DE69718808D1 (de) Plasmabehandlungsmethode
NO20013337L (no) Ny behandling
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
DE69701087D1 (de) Luftbehandlung
NO20010569D0 (no) Proteaseinhibitorer for anvendelse ved behandling av psoriasis
NO20002481D0 (no) Kombinasjonsterapi for behandling av AIDS
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
NO20012540D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
DK1135128T3 (da) Nye behandlingsfremgangsmåder
NO995390D0 (no) Baerbart feltbehandlingsutstyr
NO985325D0 (no) Anvendelse av substituert azaspiran ved behandling av astma
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon
NO20013464D0 (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
SI0946175T1 (en) USE OF A COMBINATION OF H+, K+ -ATPase INHIBITORS AND GLUCOCORTICOIDS IN THE TREATMENT OF NASAL POLYPS
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia